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Patient and nonradiographic tumor characteristics
predicting lipid-poor angiomyolipoma in small
renal masses: Introducing the BEARS index
Tyler M. Bauman1, Aaron M. Potretzke2, Alec J. Wright1, Joel M. Vetter1, Theodora A. Potretzke3,
R. Sherburne Figenshau1
1

Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, Departments of 2Urology and 3Radiology, Mayo Clinic, Rochester, MN, USA

Purpose: To create a simple model using clinical variables for predicting lipid-poor angiomyolipoma (AML) in patients with small
renal masses presumed to be renal cell carcinoma (RCC) from preoperative imaging.
Materials and Methods: A series of patients undergoing partial nephrectomy (PN) for renal masses ≤4 cm was identified using
a prospectively maintained database. Patients were excluded if standard preoperative imaging was not consistent with RCC. Chi
square and Mann-Whitney U analyses were used to evaluate differences in characteristics between patients with AML and other
types of pathology. A logistic regression model was constructed for multivariable analysis of predictors of lipid-poor AML.
Results: A total of 730 patients were identified that underwent PN for renal masses ≤4 cm between 2007–2015, including 35 with
lipid-poor AML and 620 with RCC. In multivariable analysis, the following features predicted AML: female sex (odds ratio, 6.89;
95% confidence interval, 2.35–20.92; p<0.001), age <56 years (2.84; 1.21–6.66; p=0.02), and tumor size <2 cm (5.87; 2.70–12.77;
p<0.001). Sex, age, and tumor size were used to construct the BEnign Angiomyolipoma Renal Susceptibility (BEARS) index with the
following point values for each particular risk factor: female sex (2 points), age <56 years (1 point), and tumor size <2 cm (2 points).
Within the study population, the BEARS index distinguished AML from malignant lesions with an area under the curve of 0.84.
Conclusions: Young female patients with small tumors are at risk for having lipid-poor AML despite preoperative imaging consistent with RCC. Identification of these patients may reduce the incidence of unnecessary PN for benign renal lesions.
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INTRODUCTION
Renal cell carcinoma (RCC) represents 4% of all new
diagnosed malignancies, with over 62,000 new cases expected
in 2016 [1]. Many of these newly diagnosed malignancies
include incidental, small, and localized lesions, attributable

to the widespread use of abdominal imaging modalities [2].
Surgical management with partial nephrectomy (PN) is the
standard approach for most small renal lesions concerning
for RCC, with very favorable outcomes [3,4]. Imaging moda
lities are highly useful for stratifying patients at risk for
renal malignancy; however, upwards of 30% of excised
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lesions ultimately show benign pathology [5]. While there
are certainly indications for excision of benign tumors,
these lesions are often unnecessarily surgically excised
due to ambiguity of diagnosis and risk of malignancy.
Distinguishing oncocytoma or lipid-poor angiomyolipoma
(AML) from RCC is difficult [6-8], and it is clear that better
preoperative risk models are needed to prevent unnecessary
surgeries for benign lesions.
AMLs are benign kidney lesions that are normally
distinguished from RCC on imaging due to fat content.
RCC rarely contains macroscopic adiposity, while close to
5% of AMLs do not exhibit macroscopic fat upon standard
imaging and are classified as “lipid-poor AML” [7,8]. Previous
studies have used imaging characteristics to help with
distinguishing lipid-poor AML from RCC [9-16]. Despite this
progress, detection of lipid-poor AML remains difficult, and
directly conflicting results exist in the literature for some
imaging findings [15,16]. While there is a noted association
of AML with age and sex [17], there are few models that
accurately predict lipid-poor AML using preoperative patient
characteristics. Therefore, the objective of this study was to
use clinical variables to create a simple model for predicting
lipid-poor AML in patients with small renal masses
presumed to be RCC from preoperative imaging.

MATERIALS AND METHODS
1. Patient cohort

The Washington University Institutional Review Board
approved the prospective collection of patient data used in
this study (approval number: 201304085). Using a consented,
de-identified, prospectively maintained database, all patients
undergoing PN between 2007 and 2015 were retrospectively
identified. Only patients with preoperative imaging suspi
cious for malignancy were included, and this was defined as
solid enhancing masses or complicated renal cysts classified
as Bosniak category III or IV [18]. Patient were excluded if
given a previous diagnosis of von Hippel-Landau syndrome,
tuberous sclerosis, or Birt-Hogg-Dubé syndrome, or if more
than one renal mass was resected or preoperative imaging
was suspicious for benign lesions. The f inal cohort of
patients underwent a single PN for a single renal lesion
with curative intent for presumed RCC.

2. Surgical technique

Surgical approach was impacted by the following fac
tors: patient habitus, tumor location, history of abdomi
nal surgery, and surgeon and patient pref erence. A
transperitoneal approach was used f or laparoscopic
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operations with clamping of the renal vessels [19]. Open PN
was used for larger endophytic tumors and was based on
surgeon preference. Robotic-assisted PN (RAPN) operations
were performed with a retroperitoneal or transperitoneal
approach [20]. Off-clamp technique was chosen based on
tumor location, patient characteristics, and surgeon pre
ference [21].

3. Data collection

Staf f data managers and physicians prospectively
collected patient demographics, perioperative outcomes,
and tumor characteristics. AML was considered “lipidpoor” and was included in this study if adiposity was not
observed on preoperative imaging and if the lesion was
considered suspicious for malignancy. Preoperative computed
tomography (CT) or magnetic resonance imaging (MRI) was
interpreted by fellowship-trained genitourinary radiologists
before the time of surgery, and genitourinary pathologists
were responsible for making the final diagnosis.

4. Statistical analysis

Chi-square analysis, Fisher exact test, or Mann-Whitney
U-test were used to evaluate the association of preoperative
variables with lipid-poor AML. Logistic regression was
used for multivariable modeling of predictors of lipid-poor
AML using the following variables: sex, age at surgery,
preoperative hemoglobin, history of hypertension, and
tumor size. Point values for the final model were created
by normalization of odds ratios to the lowest value from
multivariate analysis, where the lowest odds ratio was
assigned a point value of one. All analysis was performed
using R v3.1.3 (R Foundation for Statistical Computing,
Vienna, Austria), and a 2-tailed p-value <0.05 was considered
significant in all analyses.

RESULTS
A total of 730 patients underwent PN at our institution
between 2007–2015 for renal masses ≤4 cm, including 110
patients (15.1%) with benign pathology upon final diagnosis
(Table 1). Of these 110 patients, 35 patients (31.8%) were
diagnosed with AML. All cases of AML were retrospectively
confirmed to be lipid-poor AML by evaluation of surgical
pathology reports.
Differences in patient characteristics between patients
with RCC (n=620) and lipid-poor AML (n=35) were then
investigated (Supplementary Table 1). Compared to patients
with RCC, patients with AML were significantly younger
(p=0.01), more likely to be female (p<0.001), had smaller
https://doi.org/10.4111/icu.2017.58.4.235
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Table 1. Demographics of patients undergoing partial nephrectomy
for ≤4-cm lesions presumed to be RCC from preoperative imaging
Characteristic
Type of partial nephrectomy
Open
Laparoscopic
RAPN
Laparoscopic converted to open
RAPN converted to open
History of diabetes
No
Yes
Missing data
History of hypertension
No
Yes
Missing data
Tumor laterality
Left
Right
Perioperative complications
No complications
Complications
Missing data
Perioperative blood transfusion
No transfusion
Perioperative transfusion
Missing data
Charlson comorbidity index
0
1
2
≥3
Missing
Tumor histology
Benign
Angiomyolipoma
Oncocytoma
Complex cyst
Other
Malignant
Age at surgery (y) (n=730)
Body mass index (kg/m2) (n=698)
Nephrometry score (n=544)
Radiographic tumor size (cm) (n=730)
Preoperative hemoglobin (g/dL) (n=611)
Preoperative creatinine (mg/dL) (n=658)

Value
26 (3.6)
84 (11.5)
615 (84.2)
1 (0.1)
4 (0.5)
515 (78.7)
139 (21.3)
76
254 (38.8)
400 (61.2)
76
344 (47.1)
386 (52.9)
589 (88.8)
74 (11.2)
67
635 (95.5)
30 (4.5)
65
342 (52.2)
135 (20.6)
93 (14.2)
84 (12.8)
76
110 (15.1)
35 (31.8)
55 (50.0)
6 (5.5)
14 (12.7)
620 (84.9)
57.5±12.1
30.6±6.9
7.2±1.8
2.5±0.8
13.9 (1.5)
0.93 (0.34)

Values are presented as number (%) or mean±standard deviation.
RCC, renal cell carcinoma; RAPN, robotic-assisted partial nephrectomy.

Investig Clin Urol 2017;58:235-240.

tumors (p<0.001) and lower nephrometry (p=0.003) scores,
were less likely to have hypertension (p=0.02), and had lower
preoperative creatinine (p<0.001) and hemoglobin (p=0.04).
Within individual components of the nephrometry score,
tumors in lipid-poor AML patients were located further
from the collecting system (low N) (p=0.02) and were more
likely to be highly exophytic (low E) (p=0.001). There was
no significant difference in body mass index, comorbidity
status, tumor laterality, anterior/posterior tumor location,
tumor location relative to polar lines, or presence of diabetes
mellitus between patients with RCC and lipid-poor AML.
A multivariable model was constructed to compare fea
tures and demographics of ≤4-cm masses in AML and RCC
patients (Table 2). The following features independently
predicted AML: female sex (odds ratio, 6.89; 95% confidence
interval, 2.35–20.92; p<0.001), age <56 years (2.84; 1.21–6.66;
p=0.02), and tumor size <2 cm (5.87; 2.70–12.77; p<0.001).
We hypothesized that these features could be used to
create a simple model to distinguish lipid-poor AML from
RCC in patients with ≤4-cm renal masses (Table 3). Sex,
age, and tumor size were used to construct the BEnign
Angiomyolipoma Renal Susceptibility (BEARS) index, where
the following point values were assigned for each particular
risk factor: female sex (2 points), age <56 (1 point), and
tumor size <2 cm (2 points). Within the study population, the
BEARS index distinguished AML from RCC lesions with an
area under the curve of 0.84 (p<0.0001) (Fig. 1). Probability
estimates for predicting lipid-poor AML were generated
based of BEARS index values (Supplementary Table 2).

DISCUSSION
The ability to distinguish benign f rom malignant
renal lesions preoperatively is important for preventing
unnecessary surgeries, undue morbidity, and excessive
medical costs. However, benign lesions such as oncocytoma
and lipid-poor AML cannot be reliably distinguished from
RCC with standard imaging modalities [6-8]. Previous studies
have investigated whether preoperative characteristics
can predict benign histology after PN [22,23]. Both Jeon et
al. [23] and Fujita et al. [22] reported that female sex and
age at surgery were independently predictive of benign
lesions. Further, Jeon et al. [23] found that earlier year of
surgery was associated with benignity, while Fujita et al. [22]
observed a relationship of exophyticity with benign lesions.
Interestingly, AML was highly represented in the cohorts
from Jeon et al. [23] (43.2% AML) and Fujita et al. [22] (41.6%
AML), which led us to hypothesize that the high AML
representation was driving the predictive factors observed
www.icurology.org
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Table 2. Multivariable analysis of preoperative predictors of angiomyolipoma vs. malignant histology in renal masses ≤4 cm
Characteristic
Sex
Male
Female
Age at surgery (y)
≥56
<56
Radiographic tumor size (cm)
≥2
<2
History of hypertension
No
Yes
Preoperative hemoglobin (g/dL)

Odds ratio (95% CI)

p-value

Reference
6.89 (2.35–20.92)

<0.001

Reference
2.84 (1.21–6.66)

0.02

Reference
5.87 (2.70–12.77)

<0.001

Reference
0.60 (0.27–1.36)
0.96 (0.71–1.30)

0.22
0.81

CI, confidence interval.
Table 3. The BEARS index for prediction of angiomyolipoma in renal
masses ≤4 cm
Points
0
2
0
1
0
2

BEARS, BEnign Angiomyolipoma Renal Susceptibility.

in these studies. This was further corroborated by our
institutional experience, where sex and age did not predict
benignity in a cohort of patients with higher oncocytoma
representation (51.2%) and a lower proportion of AML (28.6%).
There is a known association of AML with middleaged females [17], and in this study, both age and sex were
strong predictors of lipid-poor AML in multivariate analysis,
suggesting that these variables also apply to lipid-poor AML
in addition to lipid-rich AML. Interestingly, we limited our
cohort to patients with tumors ≤4 cm given the small size
of most lipid-poor AMLs and difficulty in management
of small renal masses [24]. Despite limiting our cohort to
tumors ≤4 cm, tumor size was the second strongest predictor
of AML in our patients, with an odds ratio of 5.87. By
combining these variables to create the BEARS index, we
were able to accurately distinguish lipid-poor AML from
RCC with an AUC of 0.84. From these data, we conclude
that younger female patients with renal tumors <2 cm are
at high risk of having AML instead of RCC, and alternative
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Sensitivity

Characteristic
Sex
Male
Female
Age at surgery (y)
≥56
<56
Radiographic tumor size (cm)
≥2
<2

100

60
40
20

AUC=0.84
p<0.0001

0
0

20

40

60

80

100

100-Specificity

Fig. 1. Receiver operating characteristic analysis of the ability of the BEnign Angiomyolipoma Renal Susceptibility (BEARS) index to differentiate
lipid-poor angiomyolipoma and renal cell carcinoma in renal masses ≤4
cm. The BEARS index was calculated for each patient using sex, tumor
size, and age at surgery. The index significantly predicted lipid-poor angiomyolipoma histology after partial nephrectomy (area under the curve
[AUC]=0.84; p<0.0001).

management decisions, including possible biopsy, should be
considered before extirpative therapy in these patients.
Previously, multiple studies have used imaging features
in attempt to distinguish lipid-poor AML from RCC and
other lesions [9-16]. Authors have found myriad predictive
factors of lipid-poor AML, including high attenuation on
unenhanced CT [14,25,26], a low T2-weighted signal intensity
on MRI [11,12], and homogenous tumor enhancement on
contrast CT [13,14], among other factors. However, it has
been historically challenging to reliably distinguish lipidpoor AML from RCC based upon radiographic data alone
[6-8]. There is difficulty in replicating results from previous
studies, as conflicting results exist in the literature for some
https://doi.org/10.4111/icu.2017.58.4.235
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imaging results [15,16]. Further, most patients receive either
MRI or CT imaging, but not both modalities; therefore,
imaging studies where only one modality is used limits
applicability to all patients. Herein, we introduce the BEARS
index, a simple model to predict the likelihood of AML in
patients with small renal masses ≤4 cm. This model was
highly accurate in classifying patients with masses ≤4 cm
as lipid-poor AML, and the included components are readily
available at most institutions, substantially increasing the
potential clinical applicability. Through risk stratification
and preoperative counseling, simple models such as the
BEARS index may significantly reduce the number of
patients undergoing unnecessary PN for benign lesions.
Limitations of the current study are inherently attri
butable to the retrospective design. There was variability
in imaging protocols used for renal mass characterization.
The number of patients with lipid-poor AML is a limitation,
though few studies exist with larger cohorts. The BEARS
index was created from and validated in the same cohort of
patients; while the index was accurate in classifying AML in
this set of patients, the instrument still needs to be validated
externally.

2. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999;281:
1628-31.
3. Kim SP, Thompson RH, Boorjian SA, Weight CJ, Han LC,
Murad MH, et al. Comparative effectiveness for survival and
renal function of partial and radical nephrectomy for localized
renal tumors: a systematic review and meta-analysis. J Urol
2012;188:51-7.
4. Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK,
Derweesh IH, et al. Guideline for management of the clinical
T1 renal mass. J Urol 2009;182:1271-9.
5. Marszalek M, Ponholzer A, Brössner C, Wachter J, Maier U,
Madersbacher S. Elective open nephron-sparing surgery for
renal masses: single-center experience with 129 consecutive
patients. Urology 2004;64:38-42.
6. Prasad SR, Surabhi VR, Menias CO, Raut AA, Chintapalli KN.
Benign renal neoplasms in adults: cross-sectional imaging
findings. AJR Am J Roentgenol 2008;190:158-64.
7. Fujii Y, Komai Y, Saito K, Iimura Y, Yonese J, Kawakami S, et al.
Incidence of benign pathologic lesions at partial nephrectomy
for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology 2008;72:598-602.
8. Hafron J, Fogarty JD, Hoenig DM, Li M, Berkenblit R, Gha-

CONCLUSIONS

vamian R. Imaging characteristics of minimal fat renal angio-

Young female patients with small tumors are at risk
for having lipid-poor AML despite preoperative imaging
consistent with RCC. Identification of these patients may
reduce the incidence of unnecessary PN for benign renal
lesions.

9.

myolipoma with histologic correlations. Urology 2005;66:11559. Davenport MS, Neville AM, Ellis JH, Cohan RH, Chaudhry
HS, Leder RA. Diagnosis of renal angiomyolipoma with hounsfield unit thresholds: effect of size of region of interest and
nephrographic phase imaging. Radiology 2011;260:158-65.
10. Kim JY, Kim JK, Kim N, Cho KS. CT histogram analysis: dif-

CONFLICTS OF INTEREST
The authors have nothing to disclose.

ferentiation of angiomyolipoma without visible fat from renal
cell carcinoma at CT imaging. Radiology 2008;246:472-9.
11. Sasiwimonphan K, Takahashi N, Leibovich BC, Carter RE,
Atwell TD, Kawashima A. Small (<4 cm) renal mass: differen-

SUPPLEMENTARY MATERIALS
Scan this QR code to see the supplementary Tables, or
visit http://icurology.org/src/sm/icu-58-235-s001.pdf.

tiation of angiomyolipoma without visible fat from renal cell
carcinoma utilizing MR imaging. Radiology 2012;263:160-8.
12. Jhaveri KS, Elmi A, Hosseini-Nik H, Hedgire S, Evans A,
Jewett M, et al. Predictive value of chemical-shift MRI in distinguishing clear cell renal cell carcinoma from non-clear cell
renal cell carcinoma and minimal-fat angiomyolipoma. AJR
Am J Roentgenol 2015;205:W79-86.
13. Jinzaki M, Tanimoto A, Narimatsu Y, Ohkuma K, Kurata T,
Shinmoto H, et al. Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology 1997;205:497-502.

REFERENCES
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30.
Investig Clin Urol 2017;58:235-240.

14. Kim JK, Park SY, Shon JH, Cho KS. Angiomyolipoma with
minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology 2004;230:677-84.
15. Mytsyk Y, Borys Y, Komnatska I, Dutka I, Shatynska-Mytsyk I.
www.icurology.org

239

Bauman et al
Value of the diffusion-weighted MRI in the differential diag-

K, et al. Predictors of benign histology in clinical T1a renal cell

nostics of malignant and benign kidney neoplasms - our clini-

carcinoma tumors undergoing partial nephrectomy. Int J Urol

cal experience. Pol J Radiol 2014;79:290-5.

2014;21:100-2.

16. Sasamori H, Saiki M, Suyama J, Ohgiya Y, Hirose M, Gokan T.

23. Jeon HG, Lee SR, Kim KH, Oh YT, Cho NH, Rha KH, et al.

Utility of apparent diffusion coefficients in the evaluation of

Benign lesions after partial nephrectomy for presumed renal

solid renal tumors at 3T. Magn Reson Med Sci 2014;13:89-95.

cell carcinoma in masses 4 cm or less: prevalence and predic-

17. Hajdu SI, Foote FW Jr. Angiomyolipoma of the kidney: report
of 27 cases and review of the literature. J Urol 1969;102:396401.
18. Bosniak MA. The current radiological approach to renal cysts.
Radiology 1986;158:1-10.
19. Bhayani SB. Laparoscopic partial nephrectomy: fifty cases. J
Endourol 2008;22:313-6.

tors in Korean patients. Urology 2010;76:574-9.
24. Hindman N, Ngo L, Genega EM, Melamed J, Wei J, Braza JM,
et al. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR
techniques? Radiology 2012;265:468-77.
25. Takahashi N, Leng S, Kitajima K, Gomez-Cardona D, Thapa
P, Carter RE, et al. Small (< 4 cm) renal masses: differentiation

20. Benway BM, Wang AJ, Cabello JM, Bhayani SB. Robotic partial

of angiomyolipoma without visible fat from renal cell carci-

nephrectomy with sliding-clip renorrhaphy: technique and

noma using unenhanced and contrast-enhanced CT. AJR Am J

outcomes. Eur Urol 2009;55:592-9.

Roentgenol 2015;205:1194-202.

21. Sandhu GS, Kim EH, Tanagho YS, Bhayani SB, Figenshau RS.

26. Yang CW, Shen SH, Chang YH, Chung HJ, Wang JH, Lin AT,

Robot-assisted partial nephrectomy: off-clamp technique. J

et al. Are there useful CT features to differentiate renal cell

Endourol 2013;27:4-7.

carcinoma from lipid-poor renal angiomyolipoma? AJR Am J

22. Fujita T, Iwamura M, Wakatabe Y, Nishi M, Ishii D, Matsumoto

240

www.icurology.org

Roentgenol 2013;201:1017-28.

https://doi.org/10.4111/icu.2017.58.4.235

